Cetuximab monotherapy is active in patients with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN). Results of phase II study

収録刊行物

• J Clin Oncol

  J Clin Oncol 22 5502-, 2004